Show pagesourceBacklinksCite current pageExport to PDFBack to top Share via Share via... Twitter LinkedIn Facebook Pinterest Telegram WhatsApp Yammer Reddit TeamsRecent ChangesSend via e-MailPrintPermalink × IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma Low-grade IDH-mutant gliomas: from standard post-surgical treatments to novel IDH inhibitorsUnlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomasIdentification of intrinsic imaging subtypes using clustering analysis based on dynamic contrast-enhanced magnetic resonance imaging radiomics features for gliomas: preliminary associations with gene expression profilesCharacteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA network studyA single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendrogliomaThe cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular densityEpidemiological analysis of adult-type diffuse lower-grade gliomas and incidence and prevalence estimates of diffuse IDH-mutant gliomas in FranceImpact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ idh-mutant_1p_19q-codeleted_grade_3_oligodendroglioma.txt Last modified: 2024/10/10 11:32by 127.0.0.1